Package 58118-1167-8

{"route": ["ORAL"], "spl_id": "15d3ae78-fa44-ff38-e063-6394a90a1430", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310433", "310434"], "spl_set_id": ["934fefae-b895-427c-8798-4c5462b1ecc2"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Clinical Solutions Wholesale, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BLISTER PACK (58118-1167-8)", "package_ndc": "58118-1167-8", "marketing_start_date": "20240411"}], "brand_name": "GABAPENTIN", "product_id": "58118-1167_15d3ae78-fa44-ff38-e063-6394a90a1430", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "58118-1167", "generic_name": "Gabapentin", "labeler_name": "Clinical Solutions Wholesale, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "800 mg/1"}], "application_number": "ANDA214957", "marketing_category": "ANDA", "marketing_start_date": "20211001", "listing_expiration_date": "20261231"}